We are interested in analyzing the dynamic behavior of epithelial cells undergoing common morphogenetic movements such as invagination and cell rearrangement. Such an analysis will allow us to examine the mechanisms underlying these cell movements. We use the sea urchin embryo as our model system for several reasons. It is relatively simply organized consisting of an epithelial monolayer and is transparent which makes it highly amenable to n-dcroscopy. Gastrulation in the sea urchin embryo involves a series of morphogenetic movements whose underlying mechanisms are not understood. At the onset of gastrulation the vegetal plate of the embryo buckles into the blastocoel. This invagination ultimately forms a stout, flat-topped cylinder called the archefiteron. Ultimately, through cell rearrangement, the archenteron spans the entire blastocoel contacting the animal pole. In order to understand the mechanisms underlying gastrulation we are examining the individual cell movements and behaviors which occur during this process in living embryos. To perform this dynamic analysis, we have utilized the 2 photon system in conjunction with two dye labeling techniques. The first dye we have used is the lipophilic dye Dil. Dil randomly labels single cells in the embryo. By panning through a field of labeled embryos we chose the ones with cells labeled in the archenteron and then do time lapse filming of the labeled cell as gastrulation proceeds. Thus we have a dynamic account of a single cell's behavior. The second dye we have used is FM464 which labels the membranes of all the cells in the embryo. Therefore, we are able to analyze the movements of all the cells in the archenteron as they move relative to one another during gastrulation. 2 photon microscopy has allowed us to film for longer periods of time due to a decreased amount of photobleaching of the dyes and poisoning of the embryos. The technique has been invaluable in providing us with the dynamic cell behavioral information we need to analyze the mechanisms of epithelial morphogenesis.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
3P41RR000570-28S1
Application #
6117279
Study Section
Project Start
1998-09-30
Project End
2000-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
28
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Malecki, Marek; Putzer, Emily; Sabo, Chelsea et al. (2014) Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies. Mol Cell Ther 2:
Malecki, Marek (2014) 'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis. Stem Cell Res Ther 5:73
Mavroudi, Maria; Zarogoulidis, Paul; Porpodis, Konstantinos et al. (2014) Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy. J Cancer Res Ther (Manch) 2:22-33
Malecki, Marek; LaVanne, Christine; Alhambra, Dominique et al. (2013) Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent J Stem Cell Res Ther Suppl 9:
Malecki, Marek; Tombokan, Xenia; Anderson, Mark et al. (2013) TRA-1-60(+), SSEA-4(+), POU5F1(+), SOX2(+), NANOG(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Testes. J Stem Cell Res Ther 3:
Malecki, Marek (2013) Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies. J Stem Cell Res Ther 3:
Malecki, Marek; Dahlke, Jessica; Haig, Melissa et al. (2013) Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer. J Genet Syndr Gene Ther 4:152
Zarogoulidis, Paul; Darwiche, Kaid; Sakkas, Antonios et al. (2013) Suicide Gene Therapy for Cancer - Current Strategies. J Genet Syndr Gene Ther 4:
Malecki, Marek; Sabo, Chelsea; Putzer, Emily et al. (2013) Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration. Mol Cell Ther 1:
Malecki, Marek; Malecki, Bianca (2012) Routing of Biomolecules and Transgenes' Vectors in Nuclei of Oocytes. J Fertili In Vitro 2012:108-118

Showing the most recent 10 out of 24 publications